Eargo to Present at 39th Annual J.P. Morgan Healthcare Conference
Eargo, a medical device company focused on enhancing life for those with hearing loss, will present at the 39th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Eargo, a medical device company focused on enhancing life for those with hearing loss, will present at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021, at 2:00 PM ET. Christian Gormsen, Eargo’s CEO, will lead the presentation. The live web cast and slides are accessible at Eargo's website and will remain available for replay until February 12, 2021. Eargo offers innovative, virtually invisible hearing aids that are significantly less expensive than traditional options, enabling broader access and adoption.
Details
News Market Reaction – EAR
The recorded move for EAR in the trading session of this news was +21.98%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN JOSE, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced it will present at the 39th Annual J.P. Morgan Healthcare Conference via web cast. Christian Gormsen, Eargo’s President and Chief Executive Officer, is scheduled to present on Tuesday, January 12th at 2:00pm Eastern Time.
The live web cast of Eargo’s presentation, along with accompanying slides, can be accessed at www.eargo.com and will be available for replay through February 12, 2021.
About Eargo
Eargo is a medical device company dedicated to improving the quality of life of people with hearing loss. Our innovative product and go-to-market approach address the major challenges of traditional hearing aid adoption, including social stigma, accessibility and cost. We believe our Eargo hearing aids are the first and only virtually invisible, rechargeable, completely-in-canal, FDA regulated, exempt Class I device for the treatment of hearing loss. Our differentiated, consumer-first solution empowers consumers to take control of their hearing. Consumers can purchase online or over the phone and get personalized and convenient consultation and support from licensed hearing professionals via phone, text, email or video chat. The Eargo solution is offered to consumers at approximately half the cost of competing hearing aids purchased through traditional channels in the United States.
The company’s 4th generation product, the Eargo Neo HiFi, was launched in January and features improved capabilities across audio fidelity and bandwidth. The Eargo Neo HiFi is available for purchase here.
Related Links
http://eargo.com
Investor Contact
Nick Laudico
Vice President of Investor Relations
ir@eargo.com
Media Contact
Brad Sheets
eargo@edelman.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.